postherpetic neuralgia
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients treated with pulsed radiofrequency therapy at the Department of Anesthesiology, Kinki University Hospital 2) Patients with postherpetic neuralgia
Exclusion criteria
Exclusion criteria: 1) AST (GOT) or ALT (GPT) > 100 IU/L 2) Child-Pugh classification B or C 3) Serum creatinine greater than 2.0 mg/dL 4) Patients with a cardiac pacemaker or ICD 5) Patients with a clinical history of ischemic heart disease, arrhythmia, respiratory disease, infectious disease, metabolic disease, or autoimmune disease 6) Patients who have expressed their refusal (including verbal refusal) to this study 7) Patients who are deemed inappropriate by the principal investigator 8) Patients who are taking autonomic nerve-acting drugs, anti-arrhythmic drugs, or benzodiazepines
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of pre-treatment - post-treatment heart rate variability (HF, LF/HF) in the pulsed radiofrequency treatment effective group | — |
Countries
Japan
Contacts
Faculty of Medicine, Kindai University Depertment of Anesthesiology